The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Market-Research

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ... Read more

Submitted by Roots_Analysis on 2021-01-05 09:37.

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair

Market-Research

To order this detailed 485+ page report, please visit this ... Read more

Submitted by Roots_Analysis on 2021-01-05 09:18.

75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts

Market-Research

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

To order this 485+ page report, which

Submitted by Roots_Analysis on 2021-01-05 09:17.

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on “

Submitted by Roots_Analysis on 2021-01-05 09:17.

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.

Submitted by Roots_Analysis on 2021-01-05 09:16.

The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

Pharmaceuticals

To order this 330+ page report, please visit this link

Key Inclusions

A detailed assessment of the current

Submitted by Roots_Analysis on 2021-01-04 08:02.

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

Pharmaceuticals

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. ... Read more

Submitted by Roots_Analysis on 2021-01-04 08:01.

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on ... Read more

Submitted by Roots_Analysis on 2021-01-04 08:00.

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair

Pharmaceuticals

To order this detailed 485+ page report, please visit this ... Read more

Submitted by Roots_Analysis on 2021-01-04 07:58.

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts

Pharmaceuticals

To order this 485+ page report, which features ... Read more

Submitted by Roots_Analysis on 2021-01-04 07:58.

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on “

Submitted by Roots_Analysis on 2021-01-04 07:57.

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Submitted by Roots_Analysis on 2021-01-04 07:56.

Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030

Market-Research

To order this detailed 500+ page report, please visit this link

Key Inclusions

A detailed assessment of the

Submitted by Roots_Analysis on 2020-12-30 09:49.

More than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products for the treatment of a variety of disease indications

Market-Research

There is a growing body of evidence supporting the vast applicability and superiority of treatment outcomes of stem cell therapies, compared to conventional treatment options. In fact, the unmet needs within this domain have spurred the establishment of many start-ups in recent years.

Submitted by Roots_Analysis on 2020-12-30 09:48.

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Market-Research

Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin ( ... Read more

Submitted by Roots_Analysis on 2020-12-30 09:47.

With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis

Market-Research

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that

Submitted by Roots_Analysis on 2020-12-30 09:46.

The “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade

Market-Research

To order this 350+ page report, which features 130+ figures and 190+ tables, please visit this link

Submitted by Roots_Analysis on 2020-12-30 09:45.

Presently, there are two approved drug and over 150 product candidates, which are being evaluated for the treatment of a variety of disease indications, based on the RNAi principle, claims Roots Analysis

Market-Research

Significant advancements in the developmental pipeline across various oncological disorders, infectious diseases and genetic disorders have amplified the interest of various pharmaceutical establishments and have inspired research groups across the world, to focus their efforts on the ... Read more

Submitted by Roots_Analysis on 2020-12-30 09:44.

RNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030

Market-Research

Roots Analysis has done a detailed study on RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA ... Read more

Submitted by Roots_Analysis on 2020-12-30 09:43.

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

Market-Research

The potential therapeutic applications of RNAi were realized almost immediately after the phenomenon was first described; over the years, developers have gradually progressed their proprietary drug candidates with cautious optimism

Submitted by Roots_Analysis on 2020-12-30 09:42.

Pages